000284339 001__ 284339
000284339 005__ 20260127154537.0
000284339 0247_ $$2doi$$a10.1002/alz.052134
000284339 0247_ $$2ISSN$$a1552-5260
000284339 0247_ $$2ISSN$$a1552-5279
000284339 037__ $$aDZNE-2026-00114
000284339 082__ $$a610
000284339 1001_ $$0P:(DE-2719)9001321$$aMohr, Wiebke$$b0
000284339 1112_ $$aAlzheimer’s Association International Conference$$cDenver$$d2021-07-26 - 2021-07-30$$gAAIC 21$$wUSA
000284339 245__ $$aKey components of person‐centered care for people with dementia: A systematic review of interventions to design a patient preference study
000284339 260__ $$c2021
000284339 3367_ $$0PUB:(DE-HGF)1$$2PUB:(DE-HGF)$$aAbstract$$babstract$$mabstract$$s1769525055_6203
000284339 3367_ $$033$$2EndNote$$aConference Paper
000284339 3367_ $$2BibTeX$$aINPROCEEDINGS
000284339 3367_ $$2DRIVER$$aconferenceObject
000284339 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$mjournal
000284339 3367_ $$2DataCite$$aOutput Types/Conference Abstract
000284339 3367_ $$2ORCID$$aOTHER
000284339 520__ $$aBackground: To provide Person-Centered Care (PCC) for People with Dementia (PwD), patient’s stated preferences must be known. Data about stated care-preferences among PwD are limited. This study aimed to identify key components of PCC for PwD by a systematic review of PCC-interventions, to inform the construction of a decision model for PwD-preference elicitation.Method: A protocol was registered with PROSPERO (CRD42021225084). A search of the concepts Dementia, Person-Centered Care, and Intervention was performed in PubMed, EMBASE, and Web of Science in Nov2020. Study selection was based on 2-stage screening against eligibility criteria, limited to randomized controlled trials (RCT) and nonrandomized controlled study (NRS) designs. Risk of bias was assessed with version 2 of the Cochrane risk-of-bias tool for randomized trials (RoB2) and the Newcastle-Ottawa Scale (NOS) for nonrandomized studies. Information about authors, interventions, and outcomes were extracted and entered into an “Effects Table”. The identified PCC-interventions were thus synthesized into intervention categories to form key components of PCC.Result: Searches identified 1781 records. 19 studies (15 RCT, 4 NRS) were included after screening. The quality of the studies varied between low to moderate. The individual interventions covered a wide range of non-pharmacological, psychosocial offers, oftentimes bundled in multi-component intervention-sets. Nine intervention categories, i.e. key components of PCC to inform the construction of a decision model for PwD-preference elicitation, emerged from data synthesis: sensory enhancement/relaxation, social contact, cognitive training, validation and reminiscence, physical activities, environmental adjustments, caregiver training and support, care organization and daily living assistance. Effect measures included i.a. agitation, quality of life, antipsychotic use, depression, neuropsychiatric symptoms and behavior, with mixed results concerning the effect of the PCC interventions. All studies were conducted in nursery home or hospital settings.Conclusion: Nine intervention categories as key components of PCC to inform the construction of a decision model for PwD-preference elicitation could be identified. As the findings were limited to nursery home and hospital settings, community-dwelling PwD and the primary care-setting should find greater consideration for future investigations on PCC interventions and patient preference studies.
000284339 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000284339 588__ $$aDataset connected to CrossRef, Journals: pub.dzne.de
000284339 7001_ $$0P:(DE-2719)9001134$$aRaedke, Anika$$b1$$udzne
000284339 7001_ $$0P:(DE-2719)2812638$$aAfi, Adel$$b2
000284339 7001_ $$0P:(DE-HGF)0$$aEdvardsson, David$$b3
000284339 7001_ $$0P:(DE-2719)9001235$$aMühlichen, Franka$$b4$$udzne
000284339 7001_ $$0P:(DE-2719)9001238$$aPlaten, Moritz$$b5$$udzne
000284339 7001_ $$0P:(DE-2719)2810690$$aRoes, Martina$$b6$$udzne
000284339 7001_ $$0P:(DE-2719)2810763$$aMichalowsky, Bernhard$$b7$$udzne
000284339 7001_ $$0P:(DE-2719)2000040$$aHoffmann, Wolfgang$$b8$$udzne
000284339 773__ $$0PERI:(DE-600)2201940-6$$a10.1002/alz.052134$$gVol. 17, no. S7, p. e052134$$nS7$$pe052134$$tAlzheimer's and dementia$$v17$$x1552-5260$$y2021
000284339 8564_ $$uhttps://pub.dzne.de/record/284339/files/DZNE-2026-00114_Restricted.pdf
000284339 8564_ $$uhttps://pub.dzne.de/record/284339/files/DZNE-2026-00114_Restricted.pdf?subformat=pdfa$$xpdfa
000284339 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2025-01-06$$wger
000284339 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000284339 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-06
000284339 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-06
000284339 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-06
000284339 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-06
000284339 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-06
000284339 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-06
000284339 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-06
000284339 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000284339 9141_ $$y2021
000284339 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001321$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000284339 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001134$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000284339 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812638$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000284339 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001235$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000284339 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001238$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000284339 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810690$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000284339 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810763$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b7$$kDZNE
000284339 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000040$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b8$$kDZNE
000284339 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000284339 9201_ $$0I:(DE-2719)1510600$$kAG Hoffmann$$lTranslational Health Care Research$$x0
000284339 9201_ $$0I:(DE-2719)1610003$$kAG Roes$$lImplementation Science & Person-Centered Dementia Care$$x1
000284339 980__ $$aabstract
000284339 980__ $$aVDB
000284339 980__ $$ajournal
000284339 980__ $$aI:(DE-2719)1510600
000284339 980__ $$aI:(DE-2719)1610003
000284339 980__ $$aUNRESTRICTED